| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 10/30/2008 | US20080269344 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol |
| 10/30/2008 | US20080269197 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia |
| 10/30/2008 | US20080269176 New Salts |
| 10/30/2008 | US20080269160 Immune response against antigen in vivo; gold particle bombardment, nucleotide sequence encoding chimeric protein, antigen in one nucleic acid in an adenoviral vector; chimeric protein is myristoylation membrane targeting region; AP1903 ligand-binding region; CD40 cytoplasmic polypeptide region |
| 10/30/2008 | US20080268033 Biologically active methylene blue derivatives |
| 10/29/2008 | EP1653914A4 Oxime substituted imidazo-containing compounds |
| 10/29/2008 | CN101293869A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561lck tyrosine kinases |
| 10/29/2008 | CN100429201C Heterocyclic compounds and methods of use thereof |
| 10/28/2008 | US7442796 oxo-acids such as [3-(2,6-Dimethylbenzyloxy)-phenyl]-oxoacetic acid, used for treating insulin resistance, diabetes, hyperlipemia, liver disorders, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 10/28/2008 | US7442705 HIV replication inhibiting pyrimidines and triazines |
| 10/28/2008 | US7442702 Prostaglandin agonists |
| 10/28/2008 | CA2524300C Modified-release tablet of bupropion hydrochloride |
| 10/28/2008 | CA2358632C Drug combinations comprising (e)-7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino|pyrimidin-5-yl|(3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
| 10/28/2008 | CA2342102C Tan-1057 derivatives |
| 10/28/2008 | CA2262791C Amino acid ester containing azole antifungals |
| 10/23/2008 | US20080263607 Downloading and Transfer of Audio or Video Data from Video Broadcasts |
| 10/23/2008 | US20080261963 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 4-oxo-4H-pyrido[3,2,1-kl]benzo[g]-phenoxazine for example; Tumor suppression agents with reduced side effects; anticancer |
| 10/23/2008 | US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 10/23/2008 | US20080261909 Gene Delivery to Organs |
| 10/23/2008 | US20080260723 Method of Treatment and Bioassay Involving Macrophage Migration Inhibitory Factor (MIF) as Cardiac-Derived Myocardial Depressant Factor |
| 10/22/2008 | EP1685129A4 Oxime substituted imidazo ring compounds |
| 10/22/2008 | EP1667647A4 Monocyclic and bicyclic lactams as factor xa inhibitors |
| 10/22/2008 | EP1581123A4 Antimicrobial suture coating |
| 10/22/2008 | EP1443945B1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis or chondromalacia |
| 10/22/2008 | EP1311679B1 Method for inhibiting il-22 induced pap1 |
| 10/22/2008 | EP0787011B1 microemulsion preconcentrate comprising a macrolide |
| 10/21/2008 | US7439387 Process for the preparation of Gabapentin form-II |
| 10/21/2008 | US7439342 Thrombopoietin mimetics |
| 10/21/2008 | US7439255 3-Endo)-3-(2-cyano-2,2-diphenylethyl)-8-(cyclohexylmethyl)-8-methyl-8-azoniabicyclo[3.2.1]octane bromide; smooth muscle relaxation; respiratory system disorders: asthma, COPD, chronic bronchitis, chronic bronchiolitis and emphysema |
| 10/21/2008 | US7439221 Methods and compositions for modulating gamete adhesion |
| 10/21/2008 | US7439044 High viscosity xanthan polymer preparations |
| 10/21/2008 | US7439019 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction |
| 10/21/2008 | US7438902 treating diabetes mellitus; isolating a nestin-positive pancreatic stem cell from a pancreatic islet of a donor; transferring the stem cell into the patient, wherein it differentiates into an insulin-producing cell; across allogeneic or xenogeneic barriers and graft rejection does not occur |
| 10/21/2008 | CA2331408C Fatty analogues for the treatment of obesity, hypertension and fatty liver |
| 10/21/2008 | CA2305504C Dyeing composition for keratinous fibres with direct cationic colouring agent and a quaternary ammonium salt |
| 10/16/2008 | US20080255363 Novel Form of S-Omeprazole |
| 10/16/2008 | US20080255285 Dispersing a powder mixture of cuprous and cupric oxide in a hydrophilic polymer slurry, and extruding or molding to form water insoluble particles that release both Cu++ and Cu+ and are completely encapsulated by the polymer; nipples, gloves, condoms |
| 10/16/2008 | US20080255235 Inhibitor of a Levodopa-metabolising enzyme, a buffer, a sugar, an acid; Parkinson's disease |
| 10/16/2008 | US20080255209 Combination of a NSAID and a PDE-4 inhibitor |
| 10/16/2008 | US20080254022 Method of Treating Airway Diseases With Beta-Adrenergic Inverse Agonists |
| 10/15/2008 | EP1980564A1 Antibiotics containing borinic acid complexes and methods of use |
| 10/15/2008 | EP1685114B1 Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines. |
| 10/15/2008 | EP1628655A4 Antiseptic compositions, methods and systems |
| 10/15/2008 | EP1200116B1 USE OF FVIIa OR A TISSUE FACTOR AGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 10/15/2008 | EP0918546B1 Improvements in or relating to contrast agents |
| 10/15/2008 | EP0363415B1 Compounds for the treatment of alzheimer's disease |
| 10/15/2008 | CN101287483A Pharmaceutical compositions and methods for accelerating wound healing |
| 10/15/2008 | CN101284874A Peptide-based immunization therapy for treatment of atherosclerosis |
| 10/15/2008 | CN101284819A Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 10/15/2008 | CN100425284C Methods for glucagon suppression |
| 10/14/2008 | US7435744 Brain disorders; central nervous system disorders; viricides |
| 10/14/2008 | US7435717 Comprises doses of Apolipoprotein A-I Milano:phospholipid complex to reduce and stabilize atherosclerotic plaque; for treating ischemic reperfusion |
| 10/14/2008 | CA2331395C Fatty acid analogues for the treatment of diabetes |
| 10/09/2008 | US20080249179 histone deacetylase (HDAC) inhibitor useful in selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells; have a high bioavailability and gives high blood levels of the active compounds over a long time |
| 10/09/2008 | US20080249167 Compounds and methods for delivery of prostacyclin analogs |
| 10/09/2008 | US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide |
| 10/09/2008 | US20080249060 Nucleoside derivatives for treating hepatitis c virus infection |
| 10/09/2008 | US20080249038 Bone Morphogenetic Protein (Bmp) 2A and Uses Thereof |
| 10/09/2008 | US20080248101 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 10/09/2008 | US20080248093 pH sensitive prodrugs of 2,6-diisopropylphenol |
| 10/09/2008 | US20080248017 Multicompartment drug delivery system for use in treatment of menopausal symptoms and benign ovarian secretory disorder; contraceptive |
| 10/09/2008 | US20080247965 Metering valve and pressurized solution aerosol comprising bronchodilator, hydrofluorocarbon propellant, and cosolvent within container having inorganic coating |
| 10/08/2008 | EP1977735A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 10/08/2008 | EP1715859B1 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method |
| 10/08/2008 | EP1624843A4 Hemorrhoid treatment device |
| 10/08/2008 | EP1606283B1 P38 inhibitors and methods of use thereof |
| 10/08/2008 | CN101282741A Method for treating or preventing ischemia reperfusion injury or multi-organ failure |
| 10/08/2008 | CN100424079C Bis-sulfonamides |
| 10/08/2008 | CN100423721C Thrombopoietin mimetics |
| 10/07/2008 | US7432370 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying |
| 10/07/2008 | US7432360 Containing 0.001 to 0.01% w/v benzethonium chloride and 0.01 to 0.5% w/v phenoxyethanol or 0.01 to 0.5% w/v phenylethyl alcohol as preservatives; vials for parenteral administration |
| 10/07/2008 | US7431934 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 10/02/2008 | US20080242702 Paclitaxel enhancer compound |
| 10/02/2008 | US20080242671 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide |
| 10/02/2008 | US20080242637 Binding efficiency;cyxicity; therapy for lung, colon, ovariers tumor |
| 10/02/2008 | US20080241924 Using cell adhesion molecule specific immunoglobulin for prevention and treatment of colon, breast and cervical cancers |
| 10/01/2008 | EP1558330A4 Cycle mode providing redundant back-up to ensure termination of treatment therapy in a medical device system |
| 10/01/2008 | CN101274959A Proteinase k resistant surface protein of neisseria meningitidis |
| 10/01/2008 | CN101274928A 3-substituted-4-pyrimidone derivatives |
| 10/01/2008 | CN100422160C Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 10/01/2008 | CN100422158C Inhibitors of Akt activity |
| 10/01/2008 | CN100422151C Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 10/01/2008 | CN100421732C Plaster for the treatment of dysfunctions and disorders of nails |
| 09/30/2008 | US7429596 Oxidoreductase inhibitors; anticancer agents; antiinflammatory agents |
| 09/30/2008 | US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation |
| 09/30/2008 | US7429560 Ketoamide inhibitors in chronic nerve disease |
| 09/30/2008 | US7429559 Controlled release composition and method of producing the same |
| 09/30/2008 | US7429474 2-O sulfatase compositions and methods of analyzing therewith |
| 09/30/2008 | US7429471 regulation of matrix metalloproteinase gene expression in cartilage cells via the application of fields generated by specific and selective electric and electromagnetic signals in the treatment of diseased or injured articular cartilage. By gene expression is meant the up-regulation or down-regulation |
| 09/30/2008 | US7429389 inactivated or attenuated Mycoplasma bovis biotype and a carrier; vaccinating cows; no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections |
| 09/30/2008 | US7429375 Proteoglycan degrading mutants for the treatment of CNS |
| 09/30/2008 | CA2534507C Building element for constructing a modular substructure |
| 09/30/2008 | CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 09/25/2008 | US20080234498 Dopamine transporters; therapy for attention deficit disorders; Alzheimer's disease; Parkinson's dosease; antidepressants |
| 09/25/2008 | US20080234310 Administering cis(+-) 2,8-dimethyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole; prolonging lifespan, improving quality of life |
| 09/25/2008 | US20080234282 Especially 1-(2-(naphthylmethoxy)-1-phenylethyl)piperazine derivatives: 4-{[2-(3,chloro-4-fluorophenyl)-2-piperazin-1-ylethoxy]methyl}-3-methoxy-2-naphthonitrile; neurokinin 1 antagonists; antidepressants |
| 09/25/2008 | US20080234261 Preparation of 1,6-Disubstituted Azabenzimidazoles as Kinase Inhibitors |
| 09/25/2008 | US20080234183 Predicting or designing, detecting, and/or verifying a novel cell-penetrating peptide that mimics cellular effector activity; vectors; treating and/or preventing infectious diseases, diabetes type I and II, Alzheimer's Disease, Parkinson's Disease, and cancer. |
| 09/25/2008 | US20080233644 Chimeric Transcription Factor Decoy Oligonucleotides |
| 09/25/2008 | US20080233141 Chimera of papillomavirus capsid polypeptide L2; cervical cancers and warts; capsomeres |